Jefferies Group's MDLN Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 32,500 shares of Medline Inc. (MDLN) worth $1.45 M, representing 0.01% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Jefferies Group has initiated a new position in MDLN, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Medline (MDLN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Medline (MDLN) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +32,500 | New Buy | 32,500 | $44.50 |
Jefferies Group's Medline Investment FAQs
Jefferies Group first purchased Medline Inc. (MDLN) in Q1 2026, acquiring 32,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Medline Inc. (MDLN) for 1 quarters since Q1 2026.
Jefferies Group's largest addition to Medline Inc. (MDLN) was in Q1 2026, adding 32,500 shares worth $1.45 M.
According to the latest 13F filing for Q1 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 32,500 shares of Medline Inc. (MDLN), valued at approximately $1.45 M.
As of the Q1 2026 filing, Medline Inc. (MDLN) represents approximately 0.01% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Medline Inc. (MDLN) was 32,500 shares, as reported at the end of Q1 2026.